NCT06287320View on ClinicalTrials.gov

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Locally Advanced Non-small Cell Lung Cancer
Interventions
RADIATION

concurrent or sequential chemoradiotherapy

Thoracic radiation therapy(with the prescribed dose of 50-70 Gy), concurrently or sequentially combined with platinum-based doublet chemotherapy.

DRUG

Immunotherapy

anti-PD-1/anti-PD-L1 immune checkpoint inhibitors

Trial Locations (1)

100021

RECRUITING

Chinese Academy of Medical Science and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER